Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A study of the transfer of alpha-methyldopa to the human foetus and newborn infant.

Literature DB >> 728288

A study of the transfer of alpha-methyldopa to the human foetus and newborn infant.

H M Jones, A J Cummings.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Methyldopa

Year: 1978 PMID： 728288 PMCID： PMC1429559 DOI： 10.1111/j.1365-2125.1978.tb04609.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

5 in total

1. THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS.

Authors: R P BUHS; J L BECK; O C SPETH; J L SMITH; N R TRENNER; P J CANNON; J H LARAGH
Journal: J Pharmacol Exp Ther Date: 1964-02 Impact factor: 4.030

2. Pharmacokinetics of methyldopa in man.

Authors: K C Kwan; E L Foltz; G O Breault; J E Baer; J A Totaro
Journal: J Pharmacol Exp Ther Date: 1976-08 Impact factor: 4.030

3. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.

Authors: J A Saavedra; J L Reid; W Jordan; M D Rawlins; C T Dollery
Journal: Eur J Clin Pharmacol Date: 1975-08-14 Impact factor: 2.953

4. Fetal outcome in trial of antihypertensive treatment in pregnancy.

Authors: C W Redman
Journal: Lancet Date: 1976-10-09 Impact factor: 79.321

5. The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.

Authors: W Y Au; L G Dring; D G Grahame-Smith; P Isaac; R T Williams
Journal: Biochem J Date: 1972-08 Impact factor: 3.857

5 in total

13 in total

Review 1. Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors: P M Kyle; C W Redman
Journal: Drug Saf Date: 1992 May-Jun Impact factor: 5.606

2. Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil.

Authors: C Y Hayashida; A J Duarte; A E Sato; E H Yamashiro-Kanashiro
Journal: J Endocrinol Invest Date: 1990-12 Impact factor: 4.256

Review 3. Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors: R Loebstein; A Lalkin; G Koren
Journal: Clin Pharmacokinet Date: 1997-11 Impact factor: 6.447

Review 4. Drug kinetics in childbirth.

Authors: R L Nation
Journal: Clin Pharmacokinet Date: 1980 Jul-Aug Impact factor: 6.447

Review 9. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors: J B Besunder; M D Reed; J L Blumer
Journal: Clin Pharmacokinet Date: 1988-04 Impact factor: 6.447

Review 10. Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules.

Authors: A Heikkilä; R Erkkola
Journal: Clin Pharmacokinet Date: 1994-07 Impact factor: 6.447